(Q36563419)

14 August 2017

1 reference

title

Nebivolol: a review of its use in the management of hypertension and chronic heart failure (English)

1 reference

14 August 2017

0 references

1 reference

chronic heart failure

1 reference

2

Antona J Wagstaff

1 reference

14 August 2017

Marit D Moen

1

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

66

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

1389-409; discussion 1410

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666100-00007

14 August 2017

exact match

0 references

cites work

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666100-00007

Beta-blockers and diabetes: the bad guys come good

21 January 2018

1 reference

12 December 2020

Atenolol and cardiovascular risk: an issue close to the heart

1 reference

12 December 2020

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

12 December 2020

Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure

1 reference

12 December 2020

Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients

1 reference

12 December 2020

Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients

1 reference

12 December 2020

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

1 reference

12 December 2020

Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients.

1 reference

12 December 2020

A dose-response trial of nebivolol in essential hypertension.

1 reference

12 December 2020

Expert consensus document on beta-adrenergic receptor blockers

1 reference

12 December 2020

Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan

1 reference

12 December 2020

Demographics and concomitant disorders in heart failure

1 reference

12 December 2020

Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension

1 reference

12 December 2020

Nebivolol induces calcium-independent signaling in endothelial cells by a possible beta-adrenergic pathway

1 reference

12 December 2020

Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly

1 reference

12 December 2020

Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study

1 reference

12 December 2020

Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta

1 reference

12 December 2020

Exercise tolerance with nebivolol and atenolol

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

1 reference

12 December 2020

Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design

1 reference

12 December 2020

The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes

1 reference

12 December 2020

Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells

1 reference

12 December 2020

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population

1 reference

12 December 2020

Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents

1 reference

12 December 2020

Comparative effects of a new cardioselective beta-blocker nebivolol and nifedipine sustained-release on 24-hour ambulatory blood pressure and plasma lipoproteins

1 reference

12 December 2020

Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.

1 reference

12 December 2020

Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study

1 reference

12 December 2020

Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney

1 reference

12 December 2020

Quality of life and antihypertensive effect with nebivolol and losartan

1 reference

12 December 2020

Making sense of SENIORS.

1 reference

12 December 2020

Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?

1 reference

12 December 2020

Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy

1 reference

12 December 2020

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

1 reference

12 December 2020

Atenolol in hypertension: is it a wise choice?

1 reference

12 December 2020

Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients

1 reference

12 December 2020

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

12 December 2020

Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol

1 reference

12 December 2020

Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial

1 reference

12 December 2020

Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol

1 reference

12 December 2020

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

1 reference

12 December 2020

Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial

1 reference

12 December 2020

Guidelines from the British Hypertension Society

1 reference

12 December 2020

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

12 December 2020

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

1 reference

12 December 2020

Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study

1 reference

12 December 2020

Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

1 reference

12 December 2020

Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol

1 reference

12 December 2020

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

1 reference

12 December 2020

Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial

1 reference

12 December 2020

A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on the Sexual Function of Hypertensive Men

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS)

1 reference

12 December 2020

Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation

1 reference

12 December 2020

Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial

1 reference

12 December 2020

Effect of carvedilol on survival in severe chronic heart failure

1 reference

12 December 2020

Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.

1 reference

12 December 2020

Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial

1 reference

12 December 2020

Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker

1 reference

12 December 2020

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

12 December 2020

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine

1 reference

12 December 2020

The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery

1 reference

12 December 2020

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

12 December 2020

Effects of nebivolol on human platelet aggregation

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects

1 reference

12 December 2020

The antihypertensive and cardiac hemodynamic effects of nebivolol

1 reference

12 December 2020

Pharmacology of nebivolol

1 reference

12 December 2020

Arterial Stiffness and Risk of Coronary Heart Disease and Stroke

1 reference

12 December 2020

Nebivolol in the management of essential hypertension: a review

1 reference

12 December 2020

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

12 December 2020

Beta-blockers for heart failure: why, which, when, and where.

1 reference

12 December 2020

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

12 December 2020

Drug therapy of heart failure in the elderly

1 reference

12 December 2020

10.2165/00003495-200666100-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1031548668

0 references

1 reference